Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Monaco

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
Nature Cardiovascular Research|April 26, 2024
Erratum: Author Correction: Lipid-associated macrophages transition to an inflammatory state in human atherosclerosis, increasing the risk of cerebrovascular complicationsLea Dib, Lada A Koneva, Andreas Edsfeldt, et al.
Nature Cardiovascular Research|August 28, 2024
Publisher Correction: Lipid-associated macrophages transition to an inflammatory state in human atherosclerosis, increasing the risk of cerebrovascular complicationsLea Dib, Lada A Koneva, Andreas Edsfeldt, et al.
Nature Immunology|April 24, 2023
Neutrophils and emergency granulopoiesis drive immune suppression and an extreme response endotype during sepsisAndrew J Kwok, Alice Allcock, Ricardo C Ferreira, et al.
Circulation|July 13, 2012
Toll-like receptor 7 protects from atherosclerosis by constraining "inflammatory" macrophage activationMaria Salagianni, Ioanna E Galani, Anna M Lundberg, et al.
American Journal of Respiratory and Critical Care Medicine|September 14, 2018
Toll-like Receptor 3 Is a Therapeutic Target for Pulmonary HypertensionDaniela Farkas, A A Roger Thompson, Aneel R Bhagwani, et al.
Nature Communications|February 12, 2025
Author Correction: Dysregulation of MMP2-dependent TGF-ß2 activation impairs fibrous cap formation in type 2 diabetes-associated atherosclerosisPratibha Singh, Jiangming Sun, Michele Cavalera, et al.
Nature Communications|December 9, 2024
Dysregulation of MMP2-dependent TGF-ß2 activation impairs fibrous cap formation in type 2 diabetes-associated atherosclerosisPratibha Singh, Jiangming Sun, Michele Cavalera, et al.
European Heart Journal|December 8, 2022
Translational opportunities of single-cell biology in atherosclerosisMenno P J de Winther, Magnus Bäck, Paul Evans, et al.
Journal of the American Heart Association|August 6, 2025
Viridans Streptococcal Biofilm Evades Immune Detection and Contributes to Inflammation and Rupture of Atherosclerotic PlaquesPekka J Karhunen, Tanja Pessi, Sohvi Hörkkö, et al.
Cardiovascular Research|December 12, 2018
Identifying the anti-inflammatory response to lipid lowering therapy: a position paper from the working group on atherosclerosis and vascular biology of the European Society of CardiologyJosé Tuñón, Lina Badimón, Marie-Luce Bochaton-Piallat, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Nature Cardiovascular Research|April 26, 2024
Erratum: Author Correction: Lipid-associated macrophages transition to an inflammatory state in human atherosclerosis, increasing the risk of cerebrovascular complicationsLea Dib, Lada A Koneva, Andreas Edsfeldt, et al.
Nature Cardiovascular Research|August 28, 2024
Publisher Correction: Lipid-associated macrophages transition to an inflammatory state in human atherosclerosis, increasing the risk of cerebrovascular complicationsLea Dib, Lada A Koneva, Andreas Edsfeldt, et al.
Nature Immunology|April 24, 2023
Neutrophils and emergency granulopoiesis drive immune suppression and an extreme response endotype during sepsisAndrew J Kwok, Alice Allcock, Ricardo C Ferreira, et al.
Circulation|July 13, 2012
Toll-like receptor 7 protects from atherosclerosis by constraining "inflammatory" macrophage activationMaria Salagianni, Ioanna E Galani, Anna M Lundberg, et al.
American Journal of Respiratory and Critical Care Medicine|September 14, 2018
Toll-like Receptor 3 Is a Therapeutic Target for Pulmonary HypertensionDaniela Farkas, A A Roger Thompson, Aneel R Bhagwani, et al.
Nature Communications|February 12, 2025
Author Correction: Dysregulation of MMP2-dependent TGF-ß2 activation impairs fibrous cap formation in type 2 diabetes-associated atherosclerosisPratibha Singh, Jiangming Sun, Michele Cavalera, et al.
Nature Communications|December 9, 2024
Dysregulation of MMP2-dependent TGF-ß2 activation impairs fibrous cap formation in type 2 diabetes-associated atherosclerosisPratibha Singh, Jiangming Sun, Michele Cavalera, et al.
European Heart Journal|December 8, 2022
Translational opportunities of single-cell biology in atherosclerosisMenno P J de Winther, Magnus Bäck, Paul Evans, et al.
Journal of the American Heart Association|August 6, 2025
Viridans Streptococcal Biofilm Evades Immune Detection and Contributes to Inflammation and Rupture of Atherosclerotic PlaquesPekka J Karhunen, Tanja Pessi, Sohvi Hörkkö, et al.
Cardiovascular Research|December 12, 2018
Identifying the anti-inflammatory response to lipid lowering therapy: a position paper from the working group on atherosclerosis and vascular biology of the European Society of CardiologyJosé Tuñón, Lina Badimón, Marie-Luce Bochaton-Piallat, et al.
Pageof 12